Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 24 week, randomized, double blind, multicenter, placebo-controlled efficacy, safety, tolerability and PK trial of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) https://kusajili.fr:443/Trial/GUMqHeE5AkG9lht-S68Fcw%24a-24-week-randomized-double-blind-multicenter-placebo-controlled-efficacy-safety-tolerability-and-pk-trial-of-nilotinib-amn107-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message
